All filters
Videos
Strategy for the Elimination of Hepatitis B and C (Academy of Medicine Report) | Andrew Aronsohn, MD
Presented at:
HEP DART 2017
Videos
Roundtable discussion: Trial design, treatment endpoints and regulatory approach
Presented at:
International Workshop on HBV Cure 2017
Videos
Innovative trial design | Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017
Videos
Combination therapy how to navigate in a minefield of efficacy and toxicity? | Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2017
Videos
Other virological mechanisms | Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Videos
RNA interference | Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Videos
CCC – DNA inhibition | Anuj Gaggar, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Innate Immunity : TLR, RIG-I, STING and potential others | Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
How does HBV interact with the immune system | Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Is immunomodulation really needed to cure HBV? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement | Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
TAF – The latest update, which questions remain to be answered? | Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
What challenges remain in viral hepatitis | Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
NASH and NAFLD in HIV: same or different? | Mariana Machado, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Non liver and survival benefits of SVR in HCV | Marion Peters, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Are there any special populations in treatment of HCV left? | Douglas Dieterich, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Pharmacologist's perspective | David Back, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Videos
Virologist's perspective | Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017